Leoclan Co (TSE:7681) Research & Development: 円0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7681 Leoclan Co Ltd TSE:7681
66 GF Score
Price 円955.00
GF Value 円1,290.91
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Leoclan Co Research & Development?

Leoclan Co TSE:7681 66 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:7681 with a GF Score™ of 66/100 and a GF Value™ of 円1,290.91 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Leoclan Co's Research & Development for the six months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Leoclan Co  (TSE:7681) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Leoclan Co Research & Development Related Terms

Leoclan Co Research & Development Historical Data

* Premium members only.

The historical data trend for Leoclan Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Leoclan Co Research & Development Chart

Leoclan Co Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Leoclan Co Semi-Annual Data
Sep17 Sep18 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:7681
66GF Score
Leoclan Co Ltd TSE:7681
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Leoclan Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Leoclan Co (TSE:7681) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Leoclan Co and its competitors.
Is Leoclan Co's Research & Development too high?
Leoclan Co's current Research & Development is 円0 Mil. Overall, Leoclan Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Leoclan Co's Research & Development compare to MCK and COR?
Leoclan Co's Research & Development of 円0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Leoclan Co and its competitors. Leoclan Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leoclan Co stock overvalued right now?
Based on GuruFocus' analysis, Leoclan Co (TSE:7681) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,290.91, compared to a current price of 円955.00 — trading 26% below its estimated fair value. The current Research & Development is 円0 Mil. Leoclan Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Leoclan Co (TSE:7681), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Leoclan Co (TSE:7681) Overvalued in 2026?

Based on GuruFocus' analysis, Leoclan Co stock appears to be undervalued. The current stock price of 円955.00 is trading 26% below its estimated GF Value™ of 円1,290.91. GuruFocus considers Leoclan Co to be Modestly Undervalued.

Key valuation signals for TSE:7681:

  • Research & Development: 円0 Mil
  • GF Value™: 円1,290.91 vs. price of 円955.00 (26% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the TSE:7681 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Leoclan Co Business Description

Address 2-4-26 Senrioka, Settsu-shi, Osaka, JPN, 566-0001
Leoclan Co Ltd is a Japanese-based medical equipment trading company that meets all medical, welfare, and health needs.
66GF Score

Get the complete analysis for TSE:7681

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円955.00
Price
円1,290.91
GF Value